Back to Journals » OncoTargets and Therapy » Volume 14

Nuclear Factor-Kappa B1 Inhibits Early Apoptosis of Glioma Cells by Promoting the Expression of Bcl-2 [Retraction]

Authors Yang TQ, Chen M, Wang YQ, Xu W, Han Y, Xu J, Xiang YJ, Yuan B, Wang HZ, Zhou YX

Received 25 June 2021

Accepted for publication 25 June 2021

Published 29 June 2021 Volume 2021:14 Pages 3943—3944

DOI https://doi.org/10.2147/OTT.S326514



Yang TQ, Chen M, Wang YQ, et al. Onco Targets Ther. 2017;10:4305–4313.

 

The Editor and Publisher of OncoTargets and Therapy wish to retract the published paper. Concerns were raised that some of the western blots shown in Figure 4B, 4C and 4D may have been duplicated. The authors were unable to provide a satisfactory explanation for the alleged duplication and they were unable to provide satisfactory raw data for the western blots shown in the paper. The findings of the study were deemed to be invalid and the decision was made to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

 

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.